Fluorescent sensing for boronic acid derivatives: Design, synthesis, mechanism, application and perspective in Boron Neutron Capture Therapy (BNCT)
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Boron Compounds in Chemistry · Boron and Carbon Nanomaterials Research · Organoboron and organosilicon chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (79)
Show source-provided references
1. Detection of boronic acids through excited-state intramolecular proton-transfer fluorescence10.1021/ol402714k ↗
2. Stereoselective aldol condensation of boron enolates to trans α,β-epoxy aldehydes10.1016/S0040-4039(02)00914-0 ↗
3. Ward · J Am Chem Soc · 1998 · 120 · 109810.1021/ja973686c ↗
4. Reaction of dialkylchloroboranes with ethyl diazoacetate at low temperatures. Facile two-carbon homologation under exceptionally mild conditions10.1021/ja00765a086 ↗
5. Recent developments in organoboron chemistry: old dogs, new tricks10.1016/j.chempr.2017.05.008 ↗
6. Boron chemicals in drug discovery and development: synthesis and medicinal perspective10.3390/molecules27092615 ↗
7. Boron in drug design: recent advances in the development of new therapeutic agents10.1016/j.ejmech.2019.06.092 ↗
8. Spotlight on tavaborole for the treatment of onychomycosis
9. Development of the proteasome inhibitor velcade (bortezomib)10.1081/CNV-120030218 ↗
10. Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives10.2174/156800911794519752 ↗
11. Ixazomib: first global approval10.1007/s40265-016-0548-5 ↗
12. Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis10.1021/jm0603724 ↗
13. Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH10.1021/jm050676a ↗
14. 2019
15. Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae10.1093/jac/dkt118 ↗
16. Boron delivery agents for neutron capture therapy of cancer
17. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality10.1097/00006123-199903000-00001 ↗
18. New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue10.1007/s00259-022-05975-7 ↗
19. Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture
20. Novel promising boron agents for boron neutron capture therapy: current status and outlook on the future10.1016/j.ccr.2024.215795 ↗
21. Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer10.1016/j.bmcl.2014.01.054 ↗
22. The therapeutic effects of dodecaborate containing boronophenylalanine for boron neutron capture therapy in a rat brain tumor model10.3390/biology9120437 ↗
23. Boron nitride (10BN) a prospective material for treatment of cancer by boron neutron capture therapy (BNCT)10.1016/j.matlet.2019.126832 ↗
24. Boron neutron capture therapy anti-tumor effect of nanostructured boron carbon nitride: a new potential candidate10.1016/j.inoche.2023.111318 ↗
25. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT)10.1016/j.bmc.2018.10.041 ↗
26. Detection of nuclear disintegration in a photographic emulsion10.1038/135341a0 ↗
27. Neutron flux evaluation model provided in the accelerator-based boron neutron capture therapy system employing a solid-state lithium target10.1038/s41598-021-87627-8 ↗
28. The radiation biology of boron neutron capture therapy10.2307/3579742 ↗
29. Boron neutron capture therapy for malignant brain tumors10.1007/s11060-020-03586-6 ↗
30. Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era10.1007/s10147-019-01480-4 ↗
31. Boron-containing polyamines as DNA targeting agents for neutron capture therapy of brain tumors: synthesis and biological evaluation10.1021/jm960787x ↗
32. Clinical viability of boron neutron capture therapy for personalized radiation treatment10.3390/cancers14122865 ↗
33. Molecular mechanisms of specific cellular DNA damage response and repair induced by the mixed radiation field during boron neutron capture therapy10.3389/fonc.2021.676575 ↗
34. Application of a lab-made ternary Fe-Cr-Al coil vaporizer coupled to ICP OES for boron determination in powdered food after the sample preparation in alkaline media10.1016/j.microc.2020.104875 ↗
35. Trace analysis of potentially mutagenic boronic acids and esters in drug substance by ICP-ms10.1021/acs.oprd.6b00325 ↗
36. SIMS ion microscopy imaging of boronophenylalanine (BPA) and 13C15N-labeled phenylalanine in human glioblastoma cells: relevance of subcellular scale observations to BPA-mediated boron neutron capture therapy of cancer10.1016/j.ijms.2006.09.006 ↗
37. Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS10.1039/C9AN01336A ↗
38. Flow injection fluorescence determination of dopamine using a photo induced electron transfer (PET) boronic acid derivative10.1016/j.aca.2005.02.037 ↗
39. Reasons for discordance between positron emission tomography (PET) myocardial perfusion imaging (MPI) results and subsequent management10.1007/s12350-021-02695-7 ↗
40. Positron emission tomography (PET) for cholangiocarcinoma10.1080/13651820801992583 ↗
41. Magnetic resonance-based motion correction for positron emission tomography imaging10.1053/j.semnuclmed.2012.08.007 ↗
42. High-resolution PET detector design: modelling components of intrinsic spatial resolution10.1088/0031-9155/50/2/001 ↗
43. Impact of image-space resolution modeling for studies with the high-resolution research tomograph10.2967/jnumed.107.045351 ↗
44. Evaluation of the spatial dependence of the point spread function in 2D PET image reconstruction using LOR-OSEM10.1118/1.3310381 ↗
45. Application and evaluation of a measured spatially variant system model for PET image reconstruction10.1109/TMI.2010.2040188 ↗
46. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer10.1186/1748-717X-7-146 ↗
47. The Monte Carlo simulation of the biological effect of the 10B(n, alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy10.2307/3577018 ↗
48. Molecular fluorescent sensors for in vivo imaging10.1016/j.copbio.2023.102973 ↗
49. Fluorescent Chemo sensor nano-materials for Cancer bio-markers signalling: towards development of non-invasive early detection strategies10.1016/j.dyepig.2023.111603 ↗
50. Molecule fluorescent probes for adenosine triphosphate imaging in cancer cells and in vivo10.1016/j.ccr.2021.214302 ↗
51. Evolution of electrospun nanofibers fluorescent and colorimetric sensors for environmental toxicants, pH, temperature, and cancer cells – a review with insights on applications10.1016/j.cej.2020.125431 ↗
52. A naphthalenecarboxamide based fluorescent sensor for selective detection of Fe3+ and CN‾: live cell imaging and INHIBIT logic gate operation10.1016/j.jphotochem.2023.114661 ↗
53. A new optical boron detection method10.1039/C4AY00236A ↗
54. Optical sensing of aqueous boron based on polymeric hydroxytriphenylene derivatives
55. Thermodynamic and structural study of complexation of phenylboronic acid with salicylhydroxamic acid and related ligands10.1002/aoc.4405 ↗
56. Detection of boronic acid derivatives in cells using a fluorescent sensor10.1039/C5OB00753D ↗
57. Visualization of boronic acid containing pharmaceuticals in live tumor cells using a fluorescent boronic acid sensor10.1021/acssensors.6b00522 ↗
58. Synthesis and radiation dosimetry of 4-borono-2-[18F]fluoro-D,L-phenylalanine: a target compound for PET and boron neutron capture therapy, International journal of radiation applications and instrumentation. Part A10.1016/0883-2889(91)90133-L ↗
59. FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model10.1186/s13550-014-0070-2 ↗
60. Synthesis and evaluation as MRI probe of the trifluoromethylated p-boronophenylalanine and its alcohol derivative10.1016/j.bmc.2006.12.043 ↗
61. Spotlight on tavaborole for the treatment of onychomycosis
62. Development and elucidation of a novel fluorescent boron-sensor for the analysis of boronic acid-containing compounds10.3390/s17102436 ↗
63. Selected problems with boron determination in water treatment processes. Part I: comparison of the reference methods for ICP-MS and ICP-OES determinations10.1007/s11356-016-6328-7 ↗
64. Development of a switching-type fluorescence sensor for the detection of boronic acid-containing agents10.1007/s44211-022-00158-8 ↗
65. A high-affinity fluorescent Zn2+ sensor improved by the suppression of pyridine-pyridone tautomerism and its application in living cells10.1016/j.snb.2015.02.063 ↗
66. A red-emitting fluorescence sensor for detecting boronic acid-containing agents in cells10.3390/s22197671 ↗
67. A general method to increase Stokes shift by introducing alternating vibronic structures10.1021/jacs.8b04404 ↗
68. Red-emitting boron difluoride complexes with a mega-large Stokes shift and unexpectedly high fluorescence quantum yield10.1039/C9CC09523C ↗
69. An aqueous red emitting fluorescent fluoride sensing probe exhibiting a large Stokes shift and its application in cell imaging10.1039/C3CC46630B ↗
70. Development of a 2-(2-hydroxyphenyl)-1H-benzimidazole-Based fluorescence sensor targeting boronic acids for versatile application in boron neutron capture therapy10.3390/cancers15061862 ↗
71. Boronic acid complexes with amino phenolic N,O-ligands and their use for non-covalent protein fluorescence labeling10.1016/j.bioorg.2021.104993 ↗
72. Excited-state intramolecular proton transfer and charge transfer in 2-(2′-hydroxyphenyl)benzimidazole crystals studied by polymorphs-selected electronic spectroscopy10.1039/c2cp42686b ↗
73. Rotamerism, tautomerism, and excited-state intramolecular proton transfer in 2-(4‘-N,N-Diethylamino-2‘-hydroxyphenyl)benzimidazoles: novel benzimidazoles undergoing excited-state intramolecular coupled proton and charge transfer10.1021/jp076634a ↗
74. Boron neutron capture therapy of cancer: current status and future prospects10.1158/1078-0432.CCR-05-0035 ↗
75. Exploitation of a new Schiff-base ligand for boric acid fluorescent sensing in aqueous medium with bio-imaging studies in a living plant system10.1039/C5RA08086J ↗
76. A mixed pyridine–phenol boron complex as an organic electroluminescent material10.1039/b003774p ↗
77. A fluorescent probe for selective detection of boric acids and its application for screening the conversion of the Suzuki–Miyaura coupling reaction10.1039/D3OB01171B ↗
78. Fluorometric investigation of boric acid-pyridoxal 5′ phosphate interaction: a turn-on-fluorescence assay for the detection of boric acid in water bodies and fetal bovine serum10.1016/j.microc.2023.109254 ↗
79. Design of a novel fluorescent metal-organic framework (UiO-66-NG) for the detection of boric acid in aqueous medium and bioimaging in a living plant system10.1016/j.talanta.2023.125285 ↗